ABVC BioPharma, Inc. (ABVC) Earnings History
Net Loss24 years of earnings data (2002–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
ABVC BioPharma, Inc. (ABVC) Earnings Overview
As of June 28, 2026, ABVC BioPharma, Inc. (ABVC) reported trailing twelve-month net income of -$9M, reflecting +7.1% year-over-year growth. The company earned $-0.37 per diluted share over the past four quarters.
Looking at the long-term picture, ABVC's historical earnings data spans multiple years. The company achieved its highest annual net income of $2,539 in fiscal 2004.
ABVC BioPharma, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ATHA (-$129M net income), SAVA (-$106M net income), NRXP (-$25M net income, -2336.5% margin), ABVC has comparable earnings metrics. Compare ABVC vs ATHA →
ABVC Earnings vs Peers
Earnings metrics vs comparable public companies
ABVC Historical Earnings Data (2002–2025)
24 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | -61.3% | -$7M | $-0.39 | - | - |
| 2024 | -$5M | +37.0% | -$5M | $-0.42 | -962.1% | -923.3% |
| 2023 | -$8M | +52.6% | -$7M | $-1.80 | -5109.3% | -4439.2% |
| 2022 | -$16M | -27.9% | -$15M | $-5.20 | -1693.5% | -1558.5% |
| 2021 | -$13M | -31.1% | -$12M | $-5.10 | -3608.5% | -3290.1% |
| 2020 | -$10M | -168.9% | -$9M | $-5.00 | -2027.0% | -1760.9% |
| 2019 | -$4M | +34.7% | -$3M | $-2.10 | -519.0% | -492.9% |
| 2018 | -$6M | -31.4% | -$3M | $-4.69 | -80152.1% | -40031.1% |
| 2017 | -$4M | +61.5% | -$4M | $-3.58 | - | - |
| 2016 | -$11M | -3387.9% | -$11M | $-10.80 | - | - |
| 2015 | $-315,602 | -1209.6% | $-315,602 | $-0.01 | - | - |
| 2014 | $-24,100 | +89.4% | $-24,100 | $-126.07 | - | - |
| 2013 | $-226,352 | +78.8% | $-177,259 | $-1244.19 | -2906.8% | -2276.3% |
| 2012 | -$1M | +12.2% | -$1M | $-8102.33 | -18718.6% | -20004.3% |
| 2011 | -$1M | +35.9% | -$2M | $-61418.00 | -38202.2% | -59180.7% |
| 2010 | -$2M | +63.3% | -$2M | $-139823.64 | -12793.1% | -12715.2% |
| 2009 | -$5M | +23.5% | -$5M | $-235554.18 | - | - |
| 2008 | -$7M | -45.6% | -$5M | $-55043.27 | -26982.0% | -21340.3% |
| 2007 | -$5M | -610.3% | -$4M | $-125702.70 | -11161.7% | -10596.4% |
| 2006 | $-654,807 | -109.8% | $-611,071 | $-686.46 | -1565.1% | -1460.6% |
| 2005 | $-312,041 | -12389.9% | $-301,675 | $-720.81 | -1826.5% | -1765.8% |
| 2004 | $2,539 | +110.0% | $2,007 | $68.62 | 4.4% | 3.5% |
| 2003 | $-25,363 | -26.8% | $-23,804 | $-113.23 | -185.5% | -174.1% |
| 2002 | $-20,000 | - | $-20,000 | $-89.29 | -200.0% | -200.0% |
Download Data
Export ABVC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
24+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABVC — Frequently Asked Questions
Quick answers to the most common questions about buying ABVC stock.
What is ABVC earnings per share (EPS)?
ABVC trailing twelve-month (TTM) diluted EPS is $-0.37, reflecting +7.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2002 to 2025 is available in the table on this page.
What is ABVC BioPharma, Inc.'s net income?
ABVC BioPharma, Inc. (ABVC) trailing twelve-month net income is $-9M as of 2025. Earnings grew +7.1% year-over-year.
Is ABVC profitable?
ABVC is not currently profitable on a TTM basis, reporting a net loss of $-9M. Net margin is N/A. Investors should monitor for a return to profitability.
What is ABVC's earnings growth rate?
ABVC compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2002 to 2025.
What are ABVC's profit margins?
ABVC BioPharma, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -112.8%.
Is ABVC growing earnings?
ABVC is growing earnings steadily. YoY EPS growth of +7.1% is consistent with the 5-year CAGR of N/A. TTM net income is $-9M.
What was ABVC's best earnings year?
ABVC BioPharma, Inc.'s highest annual net income on record is $2539.00, achieved in fiscal year 2004. Earnings history on this page spans 2002 to 2025 and includes all annual and quarterly figures.
What were ABVC's earnings last quarter?
ABVC's most recent reported quarter was Q1 2026. Net income was $-2M with diluted EPS of $-0.06. For a full breakdown of all quarters, see the quarterly earnings table on this page.